New Trial Data Show Hair Growth in More Alopecia Areata Patients
At 52 weeks, nearly 40% of people taking the higher dose of baricitinib had scalp hair coverage of 80% or more, according to updated clinical trial data.
Medscape Medical News
source https://www.medscape.com/viewarticle/970987?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/970987?src=rss
Comments
Post a Comment